AtriumGen Study

  • Research type

    Research Study

  • Full title

    Study of biomarkers derived from left atrium electroanatomic mapping of patients undergoing first time atrial fibrillation ablation.

  • IRAS ID

    344977

  • Contact name

    Rui Providência

  • Contact email

    r.providencia@ucl.ac.uk

  • Sponsor organisation

    University College London

  • Clinicaltrials.gov Identifier

    EP/Z000211/1, UKRI EPSRC Funder ; Z6364106/2025/01/106 health research, UCL Data Protection Registration Number

  • Duration of Study in the UK

    1 years, 6 months, 1 days

  • Research summary

    The arrhythmia atrial fibrillation (AF) is the most common heart rhythm disease, yet its underlying disease pathology
    remains to be clearly elucidated. Given its association with aging populations and the burden it imposes on
    healthcare systems due to increased hospital attendances for symptoms of arrhythmia and heart failure exacerbation,
    it is likely to have an increasing economic impact on developed economies around the world. Furthermore, whilst AF
    is not directly linked to high mortaility, it does come with a significant symptom burden and tackling the arrhythmia has
    been shown to improve quality of life when successful.
    Recent innovations in AF management have mainly come from new approaches to AF ablation, a procedure that
    isolates the electrical triggers for AF in the heart. In the last decade however, development of new pharmacological
    therapies has stalled. These ablation procedures provide data on the structural and electrical properties of the atrium,
    where this arrhythmia occurs. It is possible therefore that data from these procedures can be explored to find new
    pharmacological therapies for atrial fibrillation as well as developing a better understanding of the underlying disease
    process.
    Our project would be eligible to any patient undergoing a routine AF ablation within which electrical mapping of their
    atrium occurs. Additional samples would be taken for genetic sequencing, in order to find associations between
    genes and the electrical and structural properties of the atrium gleaned from the data obtained during the procedure.

  • REC name

    London - Bloomsbury Research Ethics Committee

  • REC reference

    25/LO/0424

  • Date of REC Opinion

    28 Jul 2025

  • REC opinion

    Further Information Favourable Opinion